Catalyst Wire Dossier Catalyst Wire Dossier

Left atrial appendage occluder (Occlutech)

left atrial appendage occluder · Occlutech International AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Left atrial appendage occluder (Occlutech), covering 2018-04-05 to 2018-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation [NA]

See pricing